Foot Strengthening to Improve Balance and Gait in Older Adults
Evaluation of a Novel Foot Strengthening Device for Improving Fall Risk, Balance, and Gait With Age
1 other identifier
interventional
160
1 country
1
Brief Summary
The goal of this clinical trial is to learn whether different foot-strengthening strategies can improve foot strength, balance, walking ability, and fall-related outcomes in middle-aged and older adults (ages 45-85 years). The main questions it aims to answer are:
- Does foot strength change from baseline after an 8-week foot-strengthening intervention?
- Do balance, gait, and physical function improve following different foot-strengthening approaches? Researchers will compare minimalist footwear use, a foot exercise program, a foot-strengthening device (ToePro), and no intervention to see if these interventions lead to greater improvements in foot strength, balance, gait, and fall-related outcomes than no intervention. Participants will:
- Complete baseline and post-intervention laboratory testing of foot strength, balance, physical function, and walking gait
- Perform foot strengthening exercises or wear minimalist footwear (if applicable) five days/week for eight weeks
- Complete daily logs to record intervention compliance
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2026
CompletedFirst Submitted
Initial submission to the registry
January 20, 2026
CompletedFirst Posted
Study publicly available on registry
February 3, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2027
February 3, 2026
January 1, 2026
12 months
January 20, 2026
January 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (15)
Change From Baseline in Hallux Flexion Strength (Curl)
Change in maximal hallux (big toe) flexion strength assessed using a standardized hallux curl test (i.e., flexion at the metatarsal interphalangeal joints) with a dynamometer. Participants perform brief maximal voluntary contractions, and peak force output is recorded. Higher values indicate greater hallux curl strength.
From enrollment to the end of the intervention at 8 weeks
Change From Baseline in Lesser Toes Flexion Strength (Curl)
Change in maximal lesser toes flexion strength assessed using a standardized lesser toes curl test (i.e., flexion at the metatarsal interphalangeal joints) with a dynamometer. Participants perform brief maximal voluntary contractions, and peak force output is recorded. Higher values indicate greater lesser toes curl strength.
From enrollment to the end of the intervention at 8 weeks
Change From Baseline in Hallux Flexion Strength (Press)
Change in maximal hallux flexion strength assessed using a toe press test that isolates hallux flexion at the metatarsophalangeal joint. Strength is measured using a force-instrumented platform, with higher values indicating greater hallux press strength.
From enrollment to the end of the intervention at 8 weeks
Change From Baseline in Lesser Toe Flexion Strength (Press)
Change in maximal lesser toes flexion strength assessed using a toe press test that isolates flexion at the metatarsophalangeal joints. Strength is measured using a force-instrumented platform, with higher values indicating greater lesser toes press strength.
From enrollment to the end of the intervention at 8 weeks
Change From Baseline in Gait Kinetic Variables
Change in gait kinetic variables derived from motion capture and force measurement systems during walking. Measures include ground reaction force variables such as peak vertical force. Values reflect loading patterns during gait.
From enrollment to the end of the intervention at 8 weeks
Change From Baseline in Joint Angles during Gait
Change in lower-limb and foot joint angles measured during walking using motion capture. Joint angles are calculated across the gait cycle and represent segmental motion of the foot and lower extremity.
From enrollment to the end of the intervention at 8 weeks
Change From Baseline in Joint Range of Motion During Gait
Change in joint range of motion (ROM) of the foot and lower extremity measured during walking using motion capture. ROM is calculated as the difference between maximum and minimum joint angles during the gait cycle.
From enrollment to the end of the intervention at 8 weeks
Change From Baseline in Stance Time During Gait
Change in stance time measured during walking using motion capture. Stance time represents the duration the foot remains in contact with the ground during each gait cycle.
From enrollment to the end of the intervention at 8 weeks
Change From Baseline in Step Length During Gait
Change in step length measured during walking using motion capture. Step length is defined as the anterior-posterior distance between successive foot contacts.
From enrollment to the end of the intervention at 8 weeks
Change From Baseline in Cadence During Gait
Change in walking cadence measured during gait analysis using motion capture. Cadence is expressed as steps per minute.
From enrollment to the end of the intervention at 8 weeks
Change From Baseline in Step Width During Gait
Change in step width measured during walking using motion capture. Step width reflects the mediolateral distance between foot placements and is used as an indicator of gait stability.
From enrollment to the end of the intervention at 8 weeks
Change From Baseline in 6-Minute Walk Test Distance
Change in distance walked during the 6-Minute Walk Test (6MWT), measured in meters. Greater distance indicates better functional walking capacity.
From enrollment to the end of the intervention at 8 weeks
Change From Baseline in 30-Second Sit-to-Stand Test Performance
Change in functional lower-extremity performance assessed using the 30-Second Sit-to-Stand Test. Outcomes include the total number of completed sit-to-stand repetitions, with higher values indicating better performance.
From enrollment to the end of the intervention at 8 weeks
Change From Baseline in 4-Stage Balance Test Performance
Change in standing balance performance assessed using the 4-Stage Balance Test. Outcomes include the ability to successfully complete progressively challenging standing positions for the required duration.
From enrollment to the end of the intervention at 8 weeks
Change From Baseline in Single-Leg Heel-Raise Test Performance
Change in plantar flexor endurance assessed using the single-leg heel-raise test. Outcomes include the number of consecutive heel raises completed with proper form, with higher values indicating greater muscular endurance.
From enrollment to the end of the intervention at 8 weeks
Secondary Outcomes (6)
Change From Baseline in IMU-Derived Gait Acceleration Magnitude
From enrollment to the end of the intervention at 8 weeks
Footwear Minimalism (Minimalist Index)
Baseline
Intervention Compliance Survey Responses
Throughout the 8-week intervention period
FitBit-Derived Moderate-to-Vigorous Physical Activity (MVPA)
Throughout the 8-week intervention period
Change From Baseline in International Physical Activity Questionnaire (IPAQ) Scores
From enrollment to the end of the intervention at 8 weeks
- +1 more secondary outcomes
Study Arms (4)
Minimalist footwear
EXPERIMENTALParticipants are instructed to wear minimalist footwear during activities of daily living for 8 weeks, progressively increasing wear time according to a standardized schedule.
Control
NO INTERVENTIONParticipants do not receive any foot-strengthening intervention and continue usual activities.
Foot strengthening device (ToePro)
ACTIVE COMPARATORParticipants use a commercially available foot-strengthening device (ToePro) for a prescribed exercise protocol over 8 weeks.
Foot exercise program
EXPERIMENTALParticipants complete a prescribed foot and ankle strengthening exercise program targeting intrinsic and extrinsic foot muscles over an 8-week period.
Interventions
Habitual use of low-cushion, low-structure footwear designed to increase intrinsic foot muscle engagement during daily activities.
Home-based exercises including toe flexion, toe press, and arch-control movements performed several times per week.
A dense foam exercise platform designed to strengthen intrinsic foot muscles through loaded toe press exercises in lengthened muscle positions.
Eligibility Criteria
You may qualify if:
- Healthy adults: age 45-85 years old
- Able to walk without an assistive walking device or lower limb prosthesis
- No history of foot or ankle surgery
- No history of regular minimalist footwear use
- No foot or ankle issues for which study activities may be contraindicated
- BMI \<= 40
You may not qualify if:
- Deemed unfit for physical activity by the Physical Activity Readiness Questionnaire (PAR-Q)
- Current or history of an unresolved musculoskeletal, neurological, cardiovascular, pulmonary/respiratory, metabolic, renal condition, disease, or problem
- Use of orthotics in daily (i.e., non-athletic) footwear
- Pregnancy
- Any other disease or problems that may affect movement or the ability to exercise even at a low intensity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
School of Public Health-Bloomington
Bloomington, Indiana, 47405, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Allison H. Gruber, PhD
Indiana University, Bloomington
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 20, 2026
First Posted
February 3, 2026
Study Start
January 1, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
June 30, 2027
Last Updated
February 3, 2026
Record last verified: 2026-01